Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil

Detalhes bibliográficos
Autor(a) principal: Cardoso, Cristiane Wanderley
Data de Publicação: 2012
Outros Autores: Pinto, Lorene Louise Silva, Reis, Mitermayer Galvão dos, Flannery, Brendan, Reis, Joice N.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFBA
Texto Completo: http://repositorio.ufba.br/ri/handle/ri/15424
Resumo: Texto completo: acesso restrito. p. 5541–5546
id UFBA-2_286cda4a79212f0d18f8fc190db7a767
oai_identifier_str oai:repositorio.ufba.br:ri/15424
network_acronym_str UFBA-2
network_name_str Repositório Institucional da UFBA
repository_id_str 1932
spelling Cardoso, Cristiane WanderleyPinto, Lorene Louise SilvaReis, Mitermayer Galvão dosFlannery, BrendanReis, Joice N.Cardoso, Cristiane WanderleyPinto, Lorene Louise SilvaReis, Mitermayer Galvão dosFlannery, BrendanReis, Joice N.2014-08-01T12:59:28Z20120264-410Xhttp://repositorio.ufba.br/ri/handle/ri/15424v. 30, n. 37Texto completo: acesso restrito. p. 5541–5546To combat rising incidence of serogroup C meningococcal disease in the city of Salvador, Brazil, the Bahia state immunization program initiated routine childhood immunization with meningococcal C conjugate vaccine (MenC) in February 2010, followed by mass MenC vaccination of city residents 10–24 years of age from May through August 2010. We analyzed trends in incidence of reported cases of meningococcal disease and serogroup distribution among meningococcal isolates identified in hospital-based surveillance in Salvador from January 2000 to December 2011 and estimated vaccine effectiveness using the screening method. Annual incidence of serogroup C meningococcal disease increased from 0.1 cases per 100,000 population during 2000–2006 to 2.3 in 2009 and 4.1 in 2010, before falling to 2.0 per 100,000 in 2011. Estimated coverage of mass vaccination reached 80%, 67% and 41% among 10–14, 15–19 and 20–24 year olds, respectively. Incidence in 2011 was significantly lower than average rates in 2008–2009 among children <5 years, but reductions among 10–24 year olds were not significant. Among 10–24 year olds, a single dose of MenC vaccine was 100% effective (95% confidence interval, 79–100%) against serogroup C meningococcal disease. Low coverage in the population targeted for mass vaccination may have limited impact on ongoing transmission of serogroup C meningococcal disease despite high vaccine effectiveness.Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-07-28T12:07:59Z No. of bitstreams: 1 Mitermayer G. Reis.pdf: 453887 bytes, checksum: d2029e78ca1d6ad83af9119a011a1221 (MD5)Approved for entry into archive by Delba Rosa (delba@ufba.br) on 2014-08-01T12:59:28Z (GMT) No. of bitstreams: 1 Mitermayer G. Reis.pdf: 453887 bytes, checksum: d2029e78ca1d6ad83af9119a011a1221 (MD5)Made available in DSpace on 2014-08-01T12:59:28Z (GMT). No. of bitstreams: 1 Mitermayer G. Reis.pdf: 453887 bytes, checksum: d2029e78ca1d6ad83af9119a011a1221 (MD5) Previous issue date: 2012http://dx.doi.org/ 10.1016/j.vaccine.2012.06.044reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBANeisseria meningitidisMeningococcal vaccineBacterial meningitisImpact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, BrazilVaccineinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10000-01-01info:eu-repo/semantics/openAccessengORIGINALMitermayer G. Reis.pdfMitermayer G. Reis.pdfapplication/pdf453887https://repositorio.ufba.br/bitstream/ri/15424/1/Mitermayer%20G.%20Reis.pdfd2029e78ca1d6ad83af9119a011a1221MD51LICENSElicense.txtlicense.txttext/plain1345https://repositorio.ufba.br/bitstream/ri/15424/2/license.txt0d4b811ef71182510d2015daa7c8a900MD52TEXTMitermayer G. Reis.pdf.txtMitermayer G. Reis.pdf.txtExtracted texttext/plain32567https://repositorio.ufba.br/bitstream/ri/15424/3/Mitermayer%20G.%20Reis.pdf.txt69cc40e11680926b0e0ed7841fa835f1MD53ri/154242022-08-08 13:17:41.803oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-08-08T16:17:41Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false
dc.title.pt_BR.fl_str_mv Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
dc.title.alternative.pt_BR.fl_str_mv Vaccine
title Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
spellingShingle Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
Cardoso, Cristiane Wanderley
Neisseria meningitidis
Meningococcal vaccine
Bacterial meningitis
title_short Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
title_full Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
title_fullStr Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
title_full_unstemmed Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
title_sort Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil
author Cardoso, Cristiane Wanderley
author_facet Cardoso, Cristiane Wanderley
Pinto, Lorene Louise Silva
Reis, Mitermayer Galvão dos
Flannery, Brendan
Reis, Joice N.
author_role author
author2 Pinto, Lorene Louise Silva
Reis, Mitermayer Galvão dos
Flannery, Brendan
Reis, Joice N.
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Cardoso, Cristiane Wanderley
Pinto, Lorene Louise Silva
Reis, Mitermayer Galvão dos
Flannery, Brendan
Reis, Joice N.
Cardoso, Cristiane Wanderley
Pinto, Lorene Louise Silva
Reis, Mitermayer Galvão dos
Flannery, Brendan
Reis, Joice N.
dc.subject.por.fl_str_mv Neisseria meningitidis
Meningococcal vaccine
Bacterial meningitis
topic Neisseria meningitidis
Meningococcal vaccine
Bacterial meningitis
description Texto completo: acesso restrito. p. 5541–5546
publishDate 2012
dc.date.issued.fl_str_mv 2012
dc.date.accessioned.fl_str_mv 2014-08-01T12:59:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufba.br/ri/handle/ri/15424
dc.identifier.issn.none.fl_str_mv 0264-410X
dc.identifier.number.pt_BR.fl_str_mv v. 30, n. 37
identifier_str_mv 0264-410X
v. 30, n. 37
url http://repositorio.ufba.br/ri/handle/ri/15424
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.pt_BR.fl_str_mv http://dx.doi.org/ 10.1016/j.vaccine.2012.06.044
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFBA
instname:Universidade Federal da Bahia (UFBA)
instacron:UFBA
instname_str Universidade Federal da Bahia (UFBA)
instacron_str UFBA
institution UFBA
reponame_str Repositório Institucional da UFBA
collection Repositório Institucional da UFBA
bitstream.url.fl_str_mv https://repositorio.ufba.br/bitstream/ri/15424/1/Mitermayer%20G.%20Reis.pdf
https://repositorio.ufba.br/bitstream/ri/15424/2/license.txt
https://repositorio.ufba.br/bitstream/ri/15424/3/Mitermayer%20G.%20Reis.pdf.txt
bitstream.checksum.fl_str_mv d2029e78ca1d6ad83af9119a011a1221
0d4b811ef71182510d2015daa7c8a900
69cc40e11680926b0e0ed7841fa835f1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)
repository.mail.fl_str_mv
_version_ 1801502541550190592

Registros relacionados